Heart Pump Device Market Size, Share, Demand And Growth Report 2033

The global Heart Pump Device Market was valued at USD 2.77 Billion in 2024 and is projected to reach USD 9.61 Billion by 2033. It is expected to grow at a CAGR of 13.80% during the forecast period from 2025 to 2033. Market growth is fueled by the rising prevalence of heart failure and advancements in medical technology, alongside increased healthcare investments and government initiatives enhancing treatment access.

The Heart Pump Device Market Size is expanding rapidly, driven by the rising prevalence of cardiovascular diseases, increasing cases of heart failure, and growing adoption of advanced mechanical circulatory support systems. Heart pump devices—such as ventricular assist devices (VADs), intra-aortic balloon pumps (IABP), and total artificial hearts—play a critical role in supporting patients with severe cardiac dysfunction, either as a bridge to transplant or as long-term therapy.

Technological advancements, including miniaturized pumps, fully implantable systems, and improved biocompatible materials, are significantly enhancing device safety, durability, and patient outcomes. Additionally, expanding healthcare infrastructure, increased awareness about advanced cardiac therapies, and favorable reimbursement policies in developed markets are boosting adoption.

With ongoing innovation in cardiac assist technologies and a growing elderly population worldwide, the Heart Pump Device Market Size is projected to witness strong growth in the coming years, supported by rising clinical demand and continued investment in life-saving cardiovascular solutions.

Study Assumption Years

Base Year: 2024
Historical Years: 2019-2024
Forecast Period: 2025-2033

Heart Pump Device Market Key Takeaways

Current Market Size (2024): USD 2.77 Billion
CAGR (2025-2033): 13.80%
Forecast Period: 2025-2033
North America dominated the market with a 38.8% share in 2024.
The market is driven by technological advancements, increasing incidence of heart failure, and supportive reimbursement policies.
Mechanical circulatory support devices are gaining acceptance as critical therapeutic options.
Hospitals account for the largest end-user segment with 83.2% market share in 2024.
Ventricular Assist Devices (VADs) hold approximately 68.7% share of the product segment in 2024.

Download a sample PDF of this report: https://www.imarcgroup.com/heart-pump-device-market-report/requestsample

Market Growth Factors

The heart pump device market growth is primarily driven by the increasing prevalence of heart diseases, particularly heart failure, affecting over 60 million people worldwide as of 2025. Technological advancements in device design, including enhanced durability, biocompatibility, and miniaturization, support more efficient and patient-friendly heart pumps. Additionally, rising healthcare investments and government initiatives aimed at improving access to advanced cardiac treatments are significant growth drivers. The widespread innovation in minimally invasive and pulsatile operation heart pumps further boost adoption globally.

Mechanical circulatory support (MCS) devices, such as ventricular assist devices (VADs), have gained rising acceptance as essential therapeutic options due to the limited availability of donor hearts for transplantation. The use of MCS extends survival, improves quality of life, and acts as a bridge to transplant or destination therapy. The demand for bridge-to-transplant (BTT) therapy leads the market, holding around 46.7% share in 2024, driven by lengthening wait times and donor organ scarcity.

The ever-growing geriatric population susceptible to cardiovascular disorders and high healthcare awareness drive device adoption. Favorable reimbursement policies, enhanced healthcare infrastructure, and increasing cardiovascular surgeries also foster market expansion. The introduction of novel products and successful clinical trials, such as CorWave's implantable pump and Abbott’s FDA-approved Tendyne system, demonstrate ongoing innovation propelling market growth.

Market Segmentation

Analysis by Product:

Ventricular Assist Devices (VADs): Left Ventricular Assist Devices (LVAD), Percutaneous Ventricular Assist Devices (PVAD), Biventricular Ventricular Assist Devices (BIVAD), Right Ventricular Assist Devices (RVAD)
Intra-Aortic Balloon Pumps
Extracorporeal Membrane Oxygenation (ECMO)
Total Artificial Hearts

*Ventricular Assist Devices (VADs) dominate the market with 68.7% share in 2024, providing critical circulatory support for advanced heart failure patients.*

Analysis by Type: